These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 30187597

  • 1. Anemia associated with increased hepcidin in two children with Castleman disease.
    Mizukami M, Yoto Y, Nishihori S, Kimura S, Tsutsumi H.
    Pediatr Int; 2018 Sep; 60(9):882-884. PubMed ID: 30187597
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Retroperitoneal mass and anemia in an adolescent.
    Burke GJ, Wei J.
    Invest Radiol; 1992 Sep; 27(9):748-50. PubMed ID: 1399459
    [No Abstract] [Full Text] [Related]

  • 4. Pelvic Castleman disease presenting as vaginal occlusion.
    Gaunt GA, Gostout BS, Remstein E, Cliby WA.
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1082-5. PubMed ID: 12423813
    [Abstract] [Full Text] [Related]

  • 5. Iron therapy resistant microcytic anaemia in a 13-year-old girl with Castleman disease.
    De Heer-Groen TA, Prakken AB, Bax NM, van Dijken PJ.
    Eur J Pediatr; 1996 Dec; 155(12):1015-7. PubMed ID: 8956935
    [Abstract] [Full Text] [Related]

  • 6. Unicentric Castleman's disease associated with hydronephrosis.
    Hsu HH, Chen YC, Fang JT, Huang CC, Shih LY, Ghuang CK.
    Urology; 2000 Nov 01; 56(5):856. PubMed ID: 11068320
    [Abstract] [Full Text] [Related]

  • 7. Correlation between hepcidin level and renal anemia.
    Yang LN, Zhang P, Tang F, Wang G, Li FE.
    Genet Mol Res; 2014 Sep 12; 13(3):7407-10. PubMed ID: 25222239
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Castleman's disease: a condition with protean manifestations.
    Roca B.
    Onkologie; 2011 Sep 12; 34(8-9):412-4. PubMed ID: 21934339
    [No Abstract] [Full Text] [Related]

  • 10. [Peripheral blood monocyte hepcidin in patients with multiple myeloma is associated with anemia of chronic disease].
    Han X, Zhou DB, Duan MH, Wang X, Zhang JP, Zhao YQ, Shen T, Wu YJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr 12; 21(2):403-9. PubMed ID: 23628042
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyaline vascular type Castleman's disease of the mesentery.
    Shiote Y, Yamane H, Ninomiya T, Kamei H.
    Intern Med; 2012 Apr 12; 51(17):2489-90. PubMed ID: 22975576
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interleukin-6-producing thymic squamous cell carcinoma associated with Castleman's disease and nephrotic syndrome.
    Matsumura N, Shiiki H, Saito N, Uramoto H, Hanatani M, Nonaka H, Nakamura S.
    Intern Med; 2002 Oct 12; 41(10):871-4. PubMed ID: 12413013
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Superior vena cava syndrome due to isolated intrapulmonary Castleman's disease.
    Kotoulas C, Panagiotou I, Kostikas K.
    Asian Cardiovasc Thorac Ann; 2017 Mar 12; 25(3):244-245. PubMed ID: 26443713
    [No Abstract] [Full Text] [Related]

  • 19. Isolated microcytic anemia disclosing a unicentric Castleman disease: The interleukin-6/hepcidin pathway?
    Vinzio S, Ciarloni L, Schlienger JL, Rohr S, Méchine A, Goichot B.
    Eur J Intern Med; 2008 Jul 12; 19(5):367-9. PubMed ID: 18549942
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.